{"nct_id":"NCT01815294","title":"A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer","status":"COMPLETED","status_verified_date":"2015-12","start_date":"2013-05","start_date_type":null,"primary_completion_date":"2014-12","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}